<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618054</url>
  </required_header>
  <id_info>
    <org_study_id>HM20025242</org_study_id>
    <nct_id>NCT05618054</nct_id>
  </id_info>
  <brief_title>Pediatric POTS: Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?</brief_title>
  <official_title>Pediatric POTS: Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to see how people with Postural tachycardia syndrome (POTS)&#xD;
      make sense of the things they see. The information may help doctors to learn more about how&#xD;
      the different parts of people's brains communicate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2023</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Periaqueductal gray region activation - looming task</measure>
    <time_frame>90 minutes</time_frame>
    <description>Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the periaqueductal gray region during the looming task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Periaqueductal gray region activation - resting</measure>
    <time_frame>90 minutes</time_frame>
    <description>Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the periaqueductal gray region while at rest</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Postural Tachycardia Syndrome</condition>
  <arm_group>
    <arm_group_label>Adolescents with POTS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents without POTS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Looming task</intervention_name>
    <description>Participants will be asked to look at some pictures during an fMRI scan. Participants will press a button when the image appears and rate the image as scary, neutral, or pleasant.</description>
    <arm_group_label>Adolescents with POTS</arm_group_label>
    <arm_group_label>Adolescents without POTS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Females 12-18 years old&#xD;
&#xD;
          -  Able to communicate and provide consent/assent&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Diagnosed with POTS (POTS will be defined standardly as a symptomatic = 40 bpm rise in&#xD;
             heart rate on tilt table study without a drop in blood pressure and with symptoms of&#xD;
             orthostatic intolerance clinically)&#xD;
&#xD;
          -  Age-matched healthy control subjects: no POTS or other neurological disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inflammatory arthritis, connective tissue or auto-immune disorder&#xD;
&#xD;
          -  Any chronic neurological disorder besides POTS&#xD;
&#xD;
          -  Evidence of unstable medical disorder, such as kidney (rising creatinine, or end-stage&#xD;
             renal failure) or liver impairment (rising AST or ALT, or end-stage with&#xD;
             coagulopathy), poorly controlled significant cardiovascular (CHF), respiratory,&#xD;
             endocrine (diabetes&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gisela Chelimsky, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gisela Chelimsky, M.D.</last_name>
    <phone>(804) 628-0145</phone>
    <email>gisela.chelimsky@vcuhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Madison Maxwell, B.S.</last_name>
    <email>maxwellme@vcu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>April 27, 2023</last_update_submitted>
  <last_update_submitted_qc>April 27, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

